2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Multi-feature computational framework for combined signatures of dementia in underrepresented settings

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objective.

          The differential diagnosis of behavioral variant frontotemporal dementia (bvFTD) and Alzheimer’s disease (AD) remains challenging in underrepresented, underdiagnosed groups, including Latinos, as advanced biomarkers are rarely available. Recent guidelines for the study of dementia highlight the critical role of biomarkers. Thus, novel cost-effective complementary approaches are required in clinical settings.

          Approach.

          We developed a novel framework based on a gradient boosting machine learning classifier, tuned by Bayesian optimization, on a multi-feature multimodal approach (combining demographic, neuropsychological, magnetic resonance imaging (MRI), and electroencephalography/functional MRI connectivity data) to characterize neurodegeneration using site harmonization and sequential feature selection. We assessed 54 bvFTD and 76 AD patients and 152 healthy controls (HCs) from a Latin American consortium (ReDLat).

          Main results.

          The multimodal model yielded high area under the curve classification values (bvFTD patients vs HCs: 0.93 (±0.01); AD patients vs HCs: 0.95 (±0.01); bvFTD vs AD patients: 0.92 (±0.01)). The feature selection approach successfully filtered non-informative multimodal markers (from thousands to dozens).

          Results.

          Proved robust against multimodal heterogeneity, sociodemographic variability, and missing data.

          Significance.

          The model accurately identified dementia subtypes using measures readily available in underrepresented settings, with a similar performance than advanced biomarkers. This approach, if confirmed and replicated, may potentially complement clinical assessments in developing countries.

          Related collections

          Most cited references84

          • Record: found
          • Abstract: found
          • Article: not found

          The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment.

          To develop a 10-minute cognitive screening tool (Montreal Cognitive Assessment, MoCA) to assist first-line physicians in detection of mild cognitive impairment (MCI), a clinical state that often progresses to dementia. Validation study. A community clinic and an academic center. Ninety-four patients meeting MCI clinical criteria supported by psychometric measures, 93 patients with mild Alzheimer's disease (AD) (Mini-Mental State Examination (MMSE) score > or =17), and 90 healthy elderly controls (NC). The MoCA and MMSE were administered to all participants, and sensitivity and specificity of both measures were assessed for detection of MCI and mild AD. Using a cutoff score 26, the MMSE had a sensitivity of 18% to detect MCI, whereas the MoCA detected 90% of MCI subjects. In the mild AD group, the MMSE had a sensitivity of 78%, whereas the MoCA detected 100%. Specificity was excellent for both MMSE and MoCA (100% and 87%, respectively). MCI as an entity is evolving and somewhat controversial. The MoCA is a brief cognitive screening tool with high sensitivity and specificity for detecting MCI as currently conceptualized in patients performing in the normal range on the MMSE.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            EEGLAB: an open source toolbox for analysis of single-trial EEG dynamics including independent component analysis

            We have developed a toolbox and graphic user interface, EEGLAB, running under the crossplatform MATLAB environment (The Mathworks, Inc.) for processing collections of single-trial and/or averaged EEG data of any number of channels. Available functions include EEG data, channel and event information importing, data visualization (scrolling, scalp map and dipole model plotting, plus multi-trial ERP-image plots), preprocessing (including artifact rejection, filtering, epoch selection, and averaging), independent component analysis (ICA) and time/frequency decompositions including channel and component cross-coherence supported by bootstrap statistical methods based on data resampling. EEGLAB functions are organized into three layers. Top-layer functions allow users to interact with the data through the graphic interface without needing to use MATLAB syntax. Menu options allow users to tune the behavior of EEGLAB to available memory. Middle-layer functions allow users to customize data processing using command history and interactive 'pop' functions. Experienced MATLAB users can use EEGLAB data structures and stand-alone signal processing functions to write custom and/or batch analysis scripts. Extensive function help and tutorial information are included. A 'plug-in' facility allows easy incorporation of new EEG modules into the main menu. EEGLAB is freely available (http://www.sccn.ucsd.edu/eeglab/) under the GNU public license for noncommercial use and open source development, together with sample data, user tutorial and extensive documentation.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found

              The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

              The National Institute on Aging and the Alzheimer's Association charged a workgroup with the task of revising the 1984 criteria for Alzheimer's disease (AD) dementia. The workgroup sought to ensure that the revised criteria would be flexible enough to be used by both general healthcare providers without access to neuropsychological testing, advanced imaging, and cerebrospinal fluid measures, and specialized investigators involved in research or in clinical trial studies who would have these tools available. We present criteria for all-cause dementia and for AD dementia. We retained the general framework of probable AD dementia from the 1984 criteria. On the basis of the past 27 years of experience, we made several changes in the clinical criteria for the diagnosis. We also retained the term possible AD dementia, but redefined it in a manner more focused than before. Biomarker evidence was also integrated into the diagnostic formulations for probable and possible AD dementia for use in research settings. The core clinical criteria for AD dementia will continue to be the cornerstone of the diagnosis in clinical practice, but biomarker evidence is expected to enhance the pathophysiological specificity of the diagnosis of AD dementia. Much work lies ahead for validating the biomarker diagnosis of AD dementia. Copyright © 2011. Published by Elsevier Inc.
                Bookmark

                Author and article information

                Journal
                101217933
                32339
                J Neural Eng
                J Neural Eng
                Journal of neural engineering
                1741-2560
                1741-2552
                7 June 2024
                25 August 2022
                25 August 2022
                14 June 2024
                : 19
                : 4
                : 10.1088/1741-2552/ac87d0
                Affiliations
                [1 ]Global Brain Health Institute (GBHI), University of California San Francisco (UCSF), CA, United States of America
                [2 ]Cognitive Neuroscience Center (CNC), Universidad de San Andrés, Buenos Aires, Argentina
                [3 ]Latin American Brain Health (BrainLat), Universidad Adolfo Ibáñez, Santiago, Chile
                [4 ]National Scientific and Technical Research Council (CONICET), Buenos Aires, Argentina
                [5 ]Department of Physics, University of Buenos Aires, Buenos Aires, Argentina
                [6 ]Medical School, Aging Institute, Psychiatry and Mental Health, Pontificia Universidad Javeriana, Bogota, Colombia
                [7 ]MAP: School of Psychological Sciences and Health, University of Strathclyde, Glasgow, United Kingdom
                [8 ]Gerosciences Center for Brain Health and Metabolism, Santiago, Chile
                [9 ]Faculty of Medicine, University of Chile, Santiago, Chile
                [10 ]Memory and Neuropsychiatric Clinic (CMYN) Neurology Department, Hospital del Salvador and University of Chile, Santiago, Chile
                [11 ]Servicio de Neurología, Departamento de Medicina, Clínica Alemana-Universidad del Desarrollo, Santiago de Chile, Chile
                [12 ]Departamento de Lingüística y Literatura, Facultad de Humanidades, Universidad de Santiago de Chile, Santiago, Chile
                [13 ]Neuroscience-Inspired Policy Initiative, Organisation for Economic Co-operation and Development and PRODEO Institute, Paris, France
                [14 ]IMPACT, The Institute for Mental and Physical Health and Clinical Translation, Deakin University, Geelong, Victoria, Australia
                [15 ]Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, TX, United States of America
                [16 ]Memory and Aging Center, Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, United States of America
                [17 ]Trinity College Dublin, Dublin, Ireland
                Author notes
                [* ]Author to whom any correspondence should be addressed. agustin.ibanez@ 123456gbhi.org
                Author information
                http://orcid.org/0000-0001-6758-5101
                Article
                NIHMS1998047
                10.1088/1741-2552/ac87d0
                11177279
                35940105
                cf21d632-a4ce-410a-a799-d8fe3700dd64

                Original content from this work may be used under the terms of the Creative Commons Attribution 4.0 licence.

                History
                Categories
                Article

                multimodal neuroimaging,neurodegeneration,harmonization,feature selection,machine learning

                Comments

                Comment on this article